Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.
Carbiotix has raised $1.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.
Carbiotix's investors include EISMEA, Sustainable Holding Sweden.
Carbiotix is headquartered in Lund, Sweden.
Carbiotix is a pre-clinical stage therapeutics company focusing on low-cost gut health testing and microbiome modulators.
Carbiotix is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Carbiotix — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/carbiotix. Accessed August 17, 2026.
VCBacked. (2024). Carbiotix — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/carbiotix
{{cite web |title=Carbiotix — Funding & Investors |url=https://www.vcbacked.co/company/carbiotix |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated